Posts tagged “GSK”
GSK sells 2 vaccines to Pfizer; Google 'revenge porn' crackdown; Tesla for the sky; Polish airline hack; eBay, Craigslist settle
In today's Bulldog wrapup of tech and life science news: GSK is selling two meningitis vaccines to Pfizer; Google cracks down on "revenge porn;' a Tesla for the skies?; Polish airline is hacked; and eBay settles a dispute with Craigslist.
GSK funds 3 startups; Congress eyes data breach; HealthCare.gov risk; facial recognition debate; Triangle Cleantech update
In today's Bulldog wrapup of technology and life science news: GlaxoSmithKline is funding three more startups at an incubator in San Diego; Congress looking into huge federal data breach; is HealthCare.gov data at risk?; facial recognition standards talks hit a roadblock; and an added position for the head of the Research Triangle Cleantech Cluster.
Drug giant GlaxoSmithKline received two doses of good news this week. An FDA committee on Thursday recommended its drug be approved for use in adults. Plus a new study says a cervical cancer vaccine appears effective with one dose.
Where there is smoke is there fire when it comes to rumors that Pfizer might try to buy troubled GlaxoSmithKline? A Wall Street analyst is the latest to speculate that a mega merger could be in the works.
Drug giant GlaxoSmithKline is teaming up with the University of North Carolina at Chapel Hill in an attempt to find a cure for AIDS. The two will form a new company called Qura Therapeutics and will launch an "HIV Cure Center" in Chapel Hill. GSK is committing $20 million over the next five years to fund the project.
The new executive chair of GlaxoSmithKline came out in support of CEO Andrew Witty on Thursday, a day after Witty disclosed his strategy for bolstering the drug giant's future. "Andrew has the complete support of the board," said Philip Hampton. GSK also disclosed its new board lineup.
As a new chair prepares to take over at GlaxoSmithKline, the drug giant says it will not spin off its majority holdings in a promising HIV drug developer. CEO Andrew Witty also says GSK won't return as much of the profits from its big deal with Novartis to shareholders.
InformationWeek's annual "Elite 100" corporate list for innovative technology includes several located in or have big operations around the Triangle as well as the City of Asheville.
Uber eyes deliveries; IBM' quantum computing advance; Yahoo CEO pay surges; GSK targets shingles; genetic testing for insurance?
In today's Bulldog wrapup of technology and life science news: Uber eyes making deliveries; IBM reports an advance in quantum computing; pay for Yahoo CEO surges; GSK's shingles drug shows promise; and are genetic tests for insurance in your future?
Drug giant Pfizer, which failed a year ago in its attempt to acquire AstraZeneca, may now be targeting GlaxoSmithKline as a takeover target, according to business news site BidnessEtc. Pfizer has steadily increased its North Carolina presence in recent years, and GSK employs thousands in the Triangle.
GSK malaria vaccine nearer OK; Aerie not giving up on glaucoma treatment; Duke Energy's Greentech award; Novartis soars; CDC's new tech tracks listeria
In the latest wrapup of technology and life science news: GSK's malaria vaccine is closer to approval after clinical trial; Aerie Pharmaceuticals not giving up on glaucoma treatment; Duke Energy wins a Greentech award; Novartis soars in wake of GSK, Eli Lilly deals; CDC uses new tech to track listeria illnesses.
Drug giant GlaxoSmithKline, which already is cutting hundreds of jobs in the Triangle and in the Philadelphia area, is now in the process of closing an office in Pittsburgh where 274 people work, according to the Pittsburgh Business Times.
Drug giant GlaxoSmithKline, which is laying off hundreds of people in Research Triangle Park and Pennsylvania, is going to build a new research and development center for vaccines in Maryland.
Google Fiber expands; Jim Goodnight's venture play; non-GMO food label; new Instagram app; GSK's next HQ in Asia
In today's Bulldog wrapup of technology and life science news: Google Fiber is expanding; Jim Goodnight's new venture play is biotech; a proposed label for non-GMO foods; Instagram has a new app; and GSK is building a new Asian headquarters.
At an event put on by the North Carolina Biotechnology Center and supported by GlaxoSmithKline, more than 300 people who are losing their jobs at GSK through layoffs gathered to hear about possible options for future employment. "There is life beyond GSK," former GlaxoWellcome CEO Robert Ingram tells the crowd.
The Bill & Melinda Gates Foundation took a major role in trying to find a vaccine to treat Ebola, even providing funding to Durham-based Chimerix. Now, Bill Gates is warning that the world must prepare for future epidemics. If we are smart, we will listen and learn from what's happened from an outbreak that has killed some 10,000 people.
AT&T's $40M error; GSK job cuts; Amazon 1-hour delivery; Salix $78M parachutes; GSK inhaler; China freedom group attacked
In today's Bulldog wrapup of technology and life science news: AT&T takes a $40M hit in a lawsuit; GSK is cutting 150 jobs in Pa.; Amazon expands 1-hour delivery service; Salix handing out $78M in golden parachutes; GSK wins OK for inhaler; and a China web freedom group is under attack.